1254941-88-2

Basic information

• Product Name: 1-(3,4-dichlorophenyl)-2-((3-methoxybenzyl)(methyl)amino)ethanone
• Synonyms: 1-(3,4-dichlorophenyl)-2-((3-methoxybenzyl)(methyl)amino)ethanone
• CAS NO: 1254941-88-2
• Molecular Weight: 338.233
• Mol File: 1254941-88-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-(3,4-dichlorophenyl)-2-((3-methoxybenzyl)(methyl)amino)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3,4-dichlorophenyl)-2-((3-methoxybenzyl)(methyl)amino)ethanone(1254941-88-2)
• EPA Substance Registry System: 1-(3,4-dichlorophenyl)-2-((3-methoxybenzyl)(methyl)amino)ethanone(1254941-88-2)

Safety Data

• Hazardous Substances Data: 1254941-88-2(Hazardous Substances Data)

Upstream product

• 41789-95-1 1-(3-methoxyphenyl)-N-methylmethanamine 
• 2632-10-2 2-bromo-1-(3,4-dichlorophenyl)ethanone 

Downstream Products

• 802051-24-7 1-(3,4-dichlorophenyl)-2-((3-methoxybenzyl)(methyl)amino)ethanol 
• 692248-97-8 4-(3,4-dichlorophenyl)-5-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline 
• 1255925-44-0 4-(3,4-dichlorophenyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl trifluoromethanesulfonate 
• 1254941-99-5 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline 
• 1254942-01-2 tert-butyl 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 
• 1255925-09-7 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinolin-7-yl trifluoromethanesulfonate 
• 1255924-39-0 4-(4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide 

Relevant articles and documents

7-([1,2,4,]TRIAZOLO[1,5,-A]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- TETRAHYDROISOQUINOLINE AND USE THEREOF

Novel [l,2,4]triazolo[l,5-α]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SAl and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-I and N-2 are also described in the present invention.

ARYL, HETEROARYL, AND HETEROCYCLE SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF

Novel aryl, heteroaryl, and non-aromatic heterocyle substituted tetrahydroisoquinolines are described in the present invention. These compounds are used in the treatment of various neurological and physiological disorders. Methods of making these compounds are also described in the present invention.